Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Marshall, David
PropertyValue
keywords Prostate
overview Primary interests: Educational methods for training radiation oncology residents. Genitourinary and gastrointestinal cancers, prostate brachytherapy, pediatric tumors, melan oma and aggressive skin cancers, sarcomas, image-guided and stereotactic radiotherapy /radiosurgery for CNS and extracranial targets, including development of image-guided and tomotherapy approaches for GU and GI cancers. Worked successfully with industry leaders to achieve the first clinical application of QuickLink(TM) device to construct custom built linked seeds in the operating room for prosta te brachytherapy. Train physicians from other institutions on the use of custom built linked seeds with real-time dosimetry for prostate brachytherapy. Delivered first SIR-Spheres(TM) Y-90 treatment for liver metastases in the state of South Carolina. Delivered first Therapsheres(TM)Y-90 treatment for hepatocellular carcinoma in the state of South Carolina. Research Interests: Methods of training physicians/residents in image-based anatomy and radiotherapy planning techniques. Vitamin D and its influence on prostate cancer and colorectal cancer. Detection and implications of circulating tumor cells in prostate cancer. Significance of single nucleotide polymorphisms in radiation sensitivity and toxicity. Clinical research protocol development regarding the treatment of GU tumors, GI tumors, and pediatric malignancies. Integration of new technologies into patient treatment strategies including stereotactic body radiosurgery. Development of image-guided radiotherapy and intensity-modulated radiation therapy (IMRT) regimens including tomotherapy for the treatment of prostate cancer, cholangio-pancreatic tumors, and other malignancies of the genitourinary and gastrointestinal systems. Integration of small molecule therapeutic and nutritional agents with radiotherapy and chemoradiotherapy and their effects on radiosensitivity. DNA-radiation chemistry and molecular effects of hypoxia and other variables of the tumor microenvironment on radiotherapy. Involves detailed Monte Carlo computer simulations of radiation physics and chemistry of clinical photon beams used in radiotherapy.
One or more keywords matched the following items that are connected to Marshall, David
Item TypeName
Academic Article Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer.
Academic Article Options and recent advances in permanent brachytherapy for prostate cancer.
Academic Article Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?
Academic Article Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.
Academic Article Vitamin D3 supplementation, low-risk prostate cancer, and health disparities.
Academic Article The multi-disciplinary management of high-risk prostate cancer.
Academic Article Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy.
Concept Prostate-Specific Antigen
Academic Article Re-irradiation for salvage of prostate cancer failures after primary radiotherapy.
Academic Article Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.
Academic Article Phase I trial of weekly docetaxel, total androgen blockade, and image-guided intensity-modulated radiotherapy for localized high-risk prostate adenocarcinoma.
Academic Article S-Glutathionylated Serine Proteinase Inhibitors as Biomarkers for Radiation Exposure in Prostate Cancer Patients.
Academic Article Long-Term Outcomes of a Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image Guided Intensity Modulated Radiation Therapy for Localized High-Risk Prostate Adenocarcinoma.
Search Criteria
  • Prostate